Skip to main navigation Skip to search Skip to main content

Antilymphoblast Globulin in Renal Transplant Patients: No Allergic Reactions

  • William J. Martin
  • , Malcolm Blumenthal
  • , Beatrice Roitman
  • , Richard Condie
  • , Richard Simmons
  • , John Najarian

Research output: Contribution to journal › Article › peer-review

Abstract

The incidence and type of allergic reactions to antilymphoblast globulin (ALG) and their relationship to skin testing, histamine release, and serum levels of ALG and anti-ALG antibodies were studied prospectively in 50 patients receiving high-dose ALG therapy intravenously for the first two weeks after renal transplantation. No clinically apparent allergic reactions occurred in the patients studied.

Original languageEnglish (US)
Pages (from-to)1729-1731
Number of pages3
JournalJAMA: The Journal of the American Medical Association
Volume236
Issue number15
DOIs
StatePublished - Oct 11 1976

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Antilymphoblast Globulin in Renal Transplant Patients: No Allergic Reactions'. Together they form a unique fingerprint.

Cite this